4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-05-041014
President and CEO acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DRISCOLL FREDERICK W · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2005-07-15 | Grant or award : show line 1 in the form | +80,000 | 122,000 | D |
Loading xslF345X02/rrd85651.xml…